Voyager Therapeutics, Inc.
VYGR· Nasdaq
VYGRVoyager Therapeutics, Inc.
Filed May 12, 2016 · 10-Q · 42 days after period end · 0001558370-16-005926
| Metric | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|
| Revenue | $4.83M | $2.58M | — |
| Net Income | -$7.19M | -$14.58M | — |
| EPS Diluted | $0.29 | $15.81 | $6.93 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Voyager Therapeutics, Inc. · CIK 1640266 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 12, 2016 · 42 d after period end
